BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen Q, Lim KRQ, Yokota T. Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy. Appl Clin Genet 2019;12:113-30. [PMID: 31308722 DOI: 10.2147/TACG.S187481] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Meyer S, Kaulfuß S, Zechel S, Kummer K, Seif Amir Hosseini A, Ernst MS, Schmidt J, Pauli S, Zschüntzsch J. Evidence of Two Novel LAMA2 Variants in a Patient With Muscular Dystrophy: Facing the Challenges of a Certain Diagnosis. Front Neurol 2022;13:893605. [DOI: 10.3389/fneur.2022.893605] [Reference Citation Analysis]
2 Nouri Z, Sarmadi A, Narrei S, Sehhati M, Tabatabaiefar MA. Whole exome sequencing identified a novel LAMA2 frameshift variant causing merosin-deficient congenital muscular dystrophy in a patient with cardiomyopathy, and autism-like behaviors. Neuromuscular Disorders 2022. [DOI: 10.1016/j.nmd.2022.07.400] [Reference Citation Analysis]
3 Bouman K, Gubbels M, van den Heuvel FM, Groothuis JT, Erasmus CE, Nijveldt R, Udink ten Cate FE, Voermans NC. Cardiac involvement in two rare neuromuscular diseases: LAMA2-related muscular dystrophy and SELENON-related myopathy. Neuromuscular Disorders 2022. [DOI: 10.1016/j.nmd.2022.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Skeffington KL, Jones FP, Suleiman MS, Caputo M, Brancaccio A, Bigotti MG. Determination of Agrin and Related Proteins Levels as a Function of Age in Human Hearts. Front Cardiovasc Med 2022;9:813904. [DOI: 10.3389/fcvm.2022.813904] [Reference Citation Analysis]
5 Vijayan P, Hack S, Yao T, Qureshi MA, Paterson AD, John R, Davenport B, Lennon R, Pei Y, Barua M. LAMA2 and LOXL4 are candidate FSGS genes. BMC Nephrol 2021;22:320. [PMID: 34565340 DOI: 10.1186/s12882-021-02524-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Bouman K, Groothuis JT, Doorduin J, van Alfen N, Udink Ten Cate FEA, van den Heuvel FMA, Nijveldt R, van Tilburg WCM, Buckens SCFM, Dittrich ATM, Draaisma JMT, Janssen MCH, Kamsteeg EJ, van Kleef ESB, Koene S, Smeitink JAM, Küsters B, van Tienen FHJ, Smeets HJM, van Engelen BGM, Erasmus CE, Voermans NC. Natural history, outcome measures and trial readiness in LAMA2-related muscular dystrophy and SELENON-related myopathy in children and adults: protocol of the LAST STRONG study. BMC Neurol 2021;21:313. [PMID: 34384384 DOI: 10.1186/s12883-021-02336-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Tan D, Ge L, Fan Y, Chang X, Wang S, Wei C, Ding J, Liu A, Wang S, Li X, Gao K, Yang H, Que C, Huang Z, Li C, Zhu Y, Mao B, Jin B, Hua Y, Zhang X, Zhang B, Zhu W, Zhang C, Wang Y, Yuan Y, Jiang Y, Rutkowski A, Bönnemann CG, Wu X, Xiong H. Natural history and genetic study of LAMA2-related muscular dystrophy in a large Chinese cohort. Orphanet J Rare Dis 2021;16:319. [PMID: 34281576 DOI: 10.1186/s13023-021-01950-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Bordini M, Zappaterra M, Soglia F, Petracci M, Davoli R. Weighted gene co-expression network analysis identifies molecular pathways and hub genes involved in broiler White Striping and Wooden Breast myopathies. Sci Rep 2021;11:1776. [PMID: 33469097 DOI: 10.1038/s41598-021-81303-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
9 Ahmad V. Prospective of extracellular matrix and drug correlations in disease management. Asian J Pharm Sci 2021;16:147-60. [PMID: 33995610 DOI: 10.1016/j.ajps.2020.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Fabian L, Dowling JJ. Zebrafish Models of LAMA2-Related Congenital Muscular Dystrophy (MDC1A). Front Mol Neurosci 2020;13:122. [PMID: 32742259 DOI: 10.3389/fnmol.2020.00122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Bigotti MG, Skeffington KL, Jones FP, Caputo M, Brancaccio A. Agrin-Mediated Cardiac Regeneration: Some Open Questions. Front Bioeng Biotechnol 2020;8:594. [PMID: 32612983 DOI: 10.3389/fbioe.2020.00594] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Barraza-Flores P, Hermann HJ, Bates CR, Allen TG, Grunert TT, Burkin DJ. Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD. Skelet Muscle 2020;10:18. [PMID: 32498713 DOI: 10.1186/s13395-020-00235-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Gawlik KI, Durbeej M. A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD. Front Mol Neurosci 2020;13:59. [PMID: 32457577 DOI: 10.3389/fnmol.2020.00059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Barraza-Flores P, Bates CR, Oliveira-Santos A, Burkin DJ. Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics. Front Mol Neurosci 2020;13:1. [PMID: 32116540 DOI: 10.3389/fnmol.2020.00001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]